This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Ireland, Israel, Italy, Japan, Mexico, Poland, Tunisia, United Kingdom, United States, South Africa
The drug FELDENE contains one active pharmaceutical ingredient (API):
1
Piroxicam
UNII 13T4O6VMAM - PIROXICAM
|
Piroxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity. It is effective regardless of the aetiology of the inflammation. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
FELDENE Capsule, FELDENE D Tablet | Pharmaceutical Benefits Scheme (AU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
M01AC01 | Piroxicam | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AC Oxicams |
M02AA07 | Piroxicam | M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 1896T, 1897W, 1898X, 5202T, 5203W, 5204X |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 522717120067017, 522717120067117, 522717120067217, 522717120067317, 522717120067417, 522717120067517, 522717120067617, 522717120067717, 522717120067817, 522718100081803 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 30185-04-12, 3037-MEE-0917 |
Country: EE | Ravimiamet | Identifier(s): 1018516 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 55382, 55806, 58085, 60070 |
Country: FR | Base de données publique des médicaments | Identifier(s): 65182102, 65898475, 67214342, 67633600 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 138762, 142326, 161757, 181683, 181687, 182568, 24557, 24559, 381333 |
Country: HK | Department of Health Drug Office | Identifier(s): 46650 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 24066 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 2669 |
Country: IT | Agenzia del Farmaco | Identifier(s): 024249029, 024249068 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2649730M1077 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 047M86, 068M87, 188M80, 439M86 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100023759, 100264530, 100290443, 100340402, 100434830, 100451782 |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 9243011, 9243012, 9243013, 9243015, 9243016 |
Country: US | FDA, National Drug Code | Identifier(s): 0069-3220, 0069-3230 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): M/3.1/0007 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.